Skip to content
value.today

Peptilogics, Inc.

Total raised
$40 M
2 rounds on record
Latest round
$36 M
Dec 2020
First round on record
Aug 2017
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Peptilogics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2020$36 MNo. 2$10 to $50 million

Peptilogics, Inc.: Raise no. 2, Dec 2020

Investors in this round

19 investors had bought by the notice of Dec 30, 2020: 19 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$36 M of $36 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jonathan Steckbeck · Executive Officer, Director
  • Catherine Mott · Director
  • Dietrich Stephan · Director
  • Hannes Holste · Director
  • Jason Camm · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jonathan Steckbeck, Chief Executive Officer. Source: SEC Form D, newest notice filed Dec 30, 2020. Read the notice at the SEC.

equitySEC
Aug 2017$4 MNo. 1$2 to $10 million

Peptilogics, Inc.: Raise no. 1, Aug 2017

Investors in this round

1 investor had bought by the notice of Aug 31, 2017: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jonathan Steckbeck · Executive Officer, Director
  • Sanjay Kakkar · Executive Officer, Director
  • Catherine Mott · Director
  • Dietrich Stephan · Director
  • Stefan Roever · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Sanjay Kakkar, Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 31, 2017. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Peptilogics, Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2020).

    SEC Form D · Dec 2020

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Dec 2020

That is all the official record says: Peptilogics, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Peptilogics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 19 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Peptilogics, Inc.
NameRoleNamed in
Jonathan SteckbeckExecutive officerDec 2020
Sanjay KakkarExecutive officerAug 2017
Catherine MottDirectorDec 2020
Dietrich StephanDirectorDec 2020
Hannes HolsteDirectorDec 2020
Jason CammDirectorDec 2020
Jonathan SteckbeckDirectorDec 2020
Sanjay KakkarDirectorAug 2017
Stefan RoeverDirectorAug 2017